CLASS ACTION UPDATE for FIZZ and GOGO: Levi & Korsinsky,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
231
CLASS ACTION UPDATE for FIZZ and GOGO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, July 20, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

National Beverage Corp.  (NASDAQ: FIZZ ) Class Period: July 17, 2014 - July 3, 2018 Lead Plaintiff Deadline: September 17, 2018

National Beverage Corp.  made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) National Beverage's sales claims and its supposed "proprietary techniques" lacked a verifiable basis; (2) the Company's Chairman and CEO engaged in a pattern of sexual misconduct between 2014 and 2016; and (3) as a result, National Beverage's public statements were materially false and misleading at all relevant times.     On May 4, 2017, National Beverage issued a press release stating that it “employs methods that no other company does in this area—VPO (velocity per outlet) and VPC (velocity per capita).”  National Beverage asserted that it “utilize[s] two proprietary techniques to magnify these measures and this creates growth never before thought possible.” Then on June 26, 2018 the Wall Street Journal reported that National Beverage had declined to provide the U.S. Securities and Exchange Commission with requested sales figures to clarify their sales claims. Then on July 3, 2018, the Wall Street Journal published an article reporting that two pilots had filed lawsuits alleging that National Beverage's CEO had sexually harassed them. 

To learn more about the FIZZ class action go to: http://www.zlk.com/pslra-d/fizz-lawsuit?wire=3 or email jlevi@levikorsinsky.com .

Gogo Inc. (NASDAQ: GOGO ) Class Period: February 27, 2017 - May 7, 2018 Lead Plaintiff Deadline: August 27, 2018

During the class period, Gogo Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Gogo’s 2Ku antenna had more reliability issues than the public was led to believe;  (2) Gogo’s 2Ku antennas required costly installation and faced costly remediation challenges or required replacement due to deicing fluids from planes infiltrating the 2Ku system, as well as manufacturing and software issues; (3) consequently, Gogo would not be able to meet its previously issued 2018 guidance; and (4) as a result, the company’s financial statements were materially false and misleading at all relevant times.

To learn more about the GOGO class action go to: http://www.zlk.com/pslra-d/gogo-inc?wire=3 or email jlevi@levikorsinsky.com .

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 jlevi@levikorsinsky.com Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com  

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jade Power Trust Celebrates Success at Annual and Special Meeting

Updated Category News Views 190

Jade Power Trust's Annual Meeting Highlights Jade Power Trust (TSXV: JPWR.H) recently concluded its Annual and Special Meeting of unitholders, where significant decisions were made to shape the future of the Trust. The meeting, organized with great attention and resources, took place with a focus on transparency and community engagement. Re-election of Board Members...

Continue Reading
Vesper Bio's Breakthrough Phase I Results for FTD Treatment

Updated Category News Views 112

Vesper Bio Reports Positive Results from Phase I Study Vesper Bio ApS, a biotech company in the clinical stage known for its advancements in sortilin receptor biology, has made significant strides with its lead candidate, VES001. This groundbreaking compound is emerging as a potentially disease-modifying treatment for patients diagnosed with frontotemporal dementia (FTD),...

Continue Reading
Texas Pacific Land Trust Achieves Record Stock Performance

Updated Category News Views 103

Texas Pacific Land Trust Reaches New Heights In a significant display of market strength, Texas Pacific Land Trust (NYSE: TPL) stock has soared to an extraordinary all-time high of $996.82. This remarkable feat highlights a period of impressive growth for the company, as its stock has demonstrated a stunning 63.04% increase over the past year. Investors are exhibiting...

Continue Reading
Headwall Photonics Partners with NV5 to Enhance ENVI Software

Updated Category News Views 77

Headwall Photonics scored a major win back in 2024, announcing a strategic partnership with NV5 that aimed to shake up the hyperspectral imaging landscape. The deal wasn’t just about another tech tie-up; it was about embedding NV5's renowned ENVI software into Headwall's offerings, which could change how users handle geospatial data. ENVI Software Integration: What’s...

Continue Reading
DZS Inc. Completes Strategic Asset Sale to AXON Networks

Updated Category News Views 222

DZS Inc. Completes Strategic Asset Sale DZS Inc. (OTC: DZSI), known for its advanced network edge, connectivity, and cloud edge software solutions, has successfully completed the sale of its service assurance and WiFi management software portfolio to AXON Networks. This transaction includes key products such as Expresse, CloudCheck, and TruSpeed, along with their...

Continue Reading